Patent · US Active

2, 4-dinitroanilino-benzoic acid: novel insulinotropic agent for the treatment of diabetes

US10183000B1 · kind B1 · utility

0Cited by

2References

3Claims

0Family size

Inventors

Humera Jahan · Karachi, PK
Muhammad Iqbal Choudhary · Karachi, PK
Mehwish Manzoor · Karachi, PK
Khalid M. Khan · Karachi, PK
Atta-ur Rahman · Karachi, PK

Key dates

Filing date	Aug 22, 2017
Grant date	Jan 22, 2019
Priority date	—
Expiry date	Aug 22, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61B5/14532
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The current study established that treatment of diabetes using compound 1(2,4-dinitroanilino-benzoic acid), an anthranilic acid derivative, by restoring the functional activities of the pancreas via its insulinotropic action.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.